As of May 26
| +0.01 / +0.01%|
The 18 analysts offering 12-month price forecasts for Eli Lilly and Co have a median target of 75.50, with a high estimate of 100.00 and a low estimate of 65.00. The median estimate represents a +1.60% increase from the last price of 74.31.
The current consensus among 19 polled investment analysts is to Hold stock in Eli Lilly and Co. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.